Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kyverna Therapeutics

2.38
+0.11004.85%
Volume:470.93K
Turnover:1.11M
Market Cap:102.75M
PE:-0.60
High:2.46
Open:2.24
Low:2.20
Close:2.27
Loading ...

Kyverna Therapeutics Inc expected to post a loss of 84 cents a share - Earnings Preview

Reuters
·
22 Mar

Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference

PR Newswire
·
04 Mar

What Makes Kyverna Therapeutics, Inc. (KYTX) a New Buy Stock

Zacks
·
11 Feb

Kyverna Therapeutics Names Naji Gehchan as Chief Medical, Development Officer

MT Newswires Live
·
22 Jan

Kyverna Therapeutics Taps Naji Gehchan as Medical and Development Chief

Dow Jones
·
22 Jan

Kyverna appoints Naji Gehchan as Chief Medical and Development Officer

TIPRANKS
·
22 Jan

Kyverna Therapeutics Appoints Naji Gehchan, Md, MBA, as Chief Medical and Development Officer

THOMSON REUTERS
·
22 Jan

Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer

PR Newswire
·
22 Jan

Here's Why We're Watching Kyverna Therapeutics' (NASDAQ:KYTX) Cash Burn Situation

Simply Wall St.
·
15 Jan

Kyverna Therapeutics: Strong Buy Rating Backed by Strategic Focus and Robust Financial Health

TIPRANKS
·
14 Jan

BRIEF-Kyverna Therapeutics To Highlight Near-Term Strategic Priorities And Key Milestones At The 43Rd Annual J.P. Morgan Healthcare Conference

Reuters
·
13 Jan

Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43Rd Annual J.p. Morgan Healthcare Conference

THOMSON REUTERS
·
13 Jan

Kyverna Therapeutics Inc - Has Cash Runway Into 2027

THOMSON REUTERS
·
13 Jan

BRIEF-Unnatural Products Appoints Abbas Kazimi And Mert Aktar To Board

Reuters
·
08 Jan

Unnatural Products Appoints Abbas Kazimi and Mert Aktar to Board of Directors

THOMSON REUTERS
·
08 Jan

Unnatural Products Appoints Abbas Kazimi and Mert Aktar to Board of Directors

GlobeNewswire
·
08 Jan